Biotech | August 09, 2021
Novavax announces COVID-19 vaccine booster data indicating four-fold increase in neutralising antibodies
Single booster dose at 6 months of NVX-CoV2373 increased wild-type neutralizing antibodies more than 4-fold versus primary vaccination series
